1690 related articles for article (PubMed ID: 24566842)
1. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.
Mease PJ; Armstrong AW
Drugs; 2014 Mar; 74(4):423-41. PubMed ID: 24566842
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
3. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
Tobin AM; Kirby B
BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
[TBL] [Abstract][Full Text] [Related]
4. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
Woolacott N; Bravo Vergel Y; Hawkins N; Kainth A; Khadjesari Z; Misso K; Light K; Asseburg C; Palmer S; Claxton K; Bruce I; Sculpher M; Riemsma R
Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
[TBL] [Abstract][Full Text] [Related]
5. Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies.
Raychaudhuri SP; Wilken R; Sukhov AC; Raychaudhuri SK; Maverakis E
J Autoimmun; 2017 Jan; 76():21-37. PubMed ID: 27836567
[TBL] [Abstract][Full Text] [Related]
6. ALIGN PsA: Advancing a Multidisciplinary Approach in PsA.
Baum EW; Schwartzman S
Semin Cutan Med Surg; 2018 Dec; 37(6S):S125-S134. PubMed ID: 30605493
[TBL] [Abstract][Full Text] [Related]
7. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
Elyoussfi S; Thomas BJ; Ciurtin C
Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
[TBL] [Abstract][Full Text] [Related]
8. Treatment of psoriasis and psoriatic arthritis.
Papoutsaki M; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
[TBL] [Abstract][Full Text] [Related]
9. Management of psoriatic arthritis among cutaneous psoriasis patients: from pathogenesis to therapy.
Hoelt P; Confavreux C; Jullien D; Villani AP
G Ital Dermatol Venereol; 2017 Oct; 152(5):458-473. PubMed ID: 28534601
[TBL] [Abstract][Full Text] [Related]
10. Infliximab in psoriasis and psoriatic arthritis.
Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
[TBL] [Abstract][Full Text] [Related]
11. Psoriatic arthritis for the dermatologist.
Tintle SJ; Gottlieb AB
Dermatol Clin; 2015 Jan; 33(1):127-48. PubMed ID: 25412788
[TBL] [Abstract][Full Text] [Related]
12. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
Singh JA; Guyatt G; Ogdie A; Gladman DD; Deal C; Deodhar A; Dubreuil M; Dunham J; Husni ME; Kenny S; Kwan-Morley J; Lin J; Marchetta P; Mease PJ; Merola JF; Miner J; Ritchlin CT; Siaton B; Smith BJ; Van Voorhees AS; Jonsson AH; Shah AA; Sullivan N; Turgunbaev M; Coates LC; Gottlieb A; Magrey M; Nowell WB; Orbai AM; Reddy SM; Scher JU; Siegel E; Siegel M; Walsh JA; Turner AS; Reston J
Arthritis Rheumatol; 2019 Jan; 71(1):5-32. PubMed ID: 30499246
[TBL] [Abstract][Full Text] [Related]
13. New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.
Palfreeman AC; McNamee KE; McCann FE
Drug Des Devel Ther; 2013; 7():201-10. PubMed ID: 23569359
[TBL] [Abstract][Full Text] [Related]
14. Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation.
Corbett M; Chehadah F; Biswas M; Moe-Byrne T; Palmer S; Soares M; Walton M; Harden M; Ho P; Woolacott N; Bojke L
Health Technol Assess; 2017 Oct; 21(56):1-326. PubMed ID: 28976302
[TBL] [Abstract][Full Text] [Related]
15. Apremilast: A Review in Psoriasis and Psoriatic Arthritis.
Deeks ED
Drugs; 2015 Aug; 75(12):1393-403. PubMed ID: 26220911
[TBL] [Abstract][Full Text] [Related]
16. An update on the diagnosis and management of psoriatic arthritis.
Weger W
G Ital Dermatol Venereol; 2011 Feb; 146(1):1-8. PubMed ID: 21317852
[TBL] [Abstract][Full Text] [Related]
17. Psoriatic arthritis for dermatologists.
Gottlieb A; Merola JF
J Dermatolog Treat; 2020 Nov; 31(7):662-679. PubMed ID: 31014154
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of psoriatic arthritis.
Brockbank J; Gladman D
Drugs; 2002; 62(17):2447-57. PubMed ID: 12421102
[TBL] [Abstract][Full Text] [Related]
19. Prospective new biologic therapies for psoriasis and psoriatic arthritis.
Mortel MR; Emer J
J Drugs Dermatol; 2010 Aug; 9(8):947-58. PubMed ID: 20684145
[TBL] [Abstract][Full Text] [Related]
20. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U
Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
